Covaris
and Bioz Have Partnered to Bring Data and Transparency to the Customer Experience
LOS ALTOS, CA,
August 1, 2018 - Bioz, Inc.,
a Silicon Valley AI data company, is proud to announce a new partnership with
Covaris, Inc., the gold standard of DNA fragmentation in Next Generation
Sequencing. By combining the latest advances in Natural Language Processing
(NLP) and Machine Learning (ML), Bioz enables the research/academic community to
access real-world use-cases allowing Covaris to further corporate transparency,
increase customer confidence, and improve the overall customer experience.
Research shows
that product usage in journal publications is the number one driver for the
purchase of experimental tools by life-science researchers. This insight becomes
even more evident as the industry increasingly curates and markets
peer-reviewed citations that mention their products. With this partnership,
Covaris now displays the most recent and relevant citations on each of their
product pages using live streamed Bioz Badges. These badges also feature the
Bioz Stars score, an objective rating based on the concept of ZERO BIAS™. Bioz'
proprietary AI software mines scientific articles for product-specific data,
then structures that objective information to share best-practices, glean
insights, and simplify the process of planning future research.
"Teaming up with
Covaris provides researchers with peer-reviewed product specific data, " said
Dr. Karin Lachmi, co-founder and CSO of Bioz. "Covaris has a clear leadership
role in focused acoustic technology and we're excited to bring their customers
the latest scientific studies supporting Covaris products. "
"We've only just
started working with Bioz and are already seeing a positive impact. Our sales
team is sharing the badge information with prospective customers who are using
the objective ranking to influence purchase decisions" said Bill Campbell, VP
Marketing at Covaris.
Suggested
Tweet: @Covaris leverages
@Bioz AI software to bring transparency and ensure user confidence through
unbiased data.
About Bioz,
Inc.
Bioz, Inc. offers
the world's first search engine for life science experimentation. The
patent-pending software platform combines the work of scientists with advanced
artificial intelligence (AI), focused on natural language processing (NLP) and
machine learning (ML) technology to help life scientists in academia and
biopharma make faster and smarter experimentation decisions, ultimately
speeding up drug discovery and increasing the rate of success in finding cures
for diseases. Founded in 2013 by Stanford research scientist, Karin Lachmi,
Ph.D., and CEO Daniel Levitt, Bioz is a Stanford-StartX accelerator company.
Over one million
researchers from academic institutions and biopharma companies in 195 countries
use Bioz. Try Bioz at www.bioz.com.
To learn more
about the Bioz Partner Program please reach out to info@bioz.com.
About Covaris,
Inc.
Covaris
provides tools and technologies to improve pre-analytical sample preparation,
enable novel drug formulations, and manage compounds in the drug discovery
process. The Covaris technological foundation is based on its proprietary and
patented Adaptive Focused Acoustics® (AFA®) technology.
AFA enables a vast array of non-contact, isothermal processes to be developed
for use in a broad range of applications in genomics, proteomics, cell biology,
drug discovery, and formulation. Thousands of Focused-ultrasonicators are in
use in over 30 countries and customers include the world's leading researchers,
universities, and pharmaceutical companies.
To learn more
about Covaris and please reach out to info@covaris.com.